Acyl hydroxypyrazoles as novel agonists for high-affinity nicotinic acid receptor GPR109A: WO2008051403

Molecular modeling aided design of nicotinic acid receptor GPR109A agonists

(2008) Qiaolin Deng et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Tetrahydro anthranilic acid as a surrogate for anthranilic acid: Application to the discovery of potent niacin receptor agonists

(2008) Subharekha Raghavan et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Effects of a niacin receptor partial agonist, MK-0354, on plasma free fatty acids, lipids, and cutaneous flushing in humans

(2008) Eseng Lai et al.   Journal of Clinical Lipidology

3-(1H-Tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): A Partial Agonist of the Nicotinic Acid Receptor, G-Protein Coupled Receptor 109a, with Antilipolytic but No Vasodilatory Activity in Mice

(2008) Graeme Semple et al.   JOURNAL OF MEDICINAL CHEMISTRY

Nicotinic Acid Receptor Agonists

(2008) P. Douglas Boatman et al.   JOURNAL OF MEDICINAL CHEMISTRY

Effects of Laropiprant on Nicotinic Acid-Induced Flushing in Patients With Dyslipidemia††A list of study investigators appears in the Appendix.

(2007) John F. Paolini et al.   AMERICAN JOURNAL OF CARDIOLOGY